1. Home
  2. HQY vs BIO Comparison

HQY vs BIO Comparison

Compare HQY & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HealthEquity Inc.

HQY

HealthEquity Inc.

N/A

Current Price

$103.55

Market Cap

8.6B

ML Signal

N/A

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$382.21

Market Cap

10.3B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
HQY
BIO
Founded
2002
1952
Country
United States
United States
Employees
N/A
7450
Industry
Business Services
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
10.3B
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
HQY
BIO
Price
$103.55
$382.21
Analyst Decision
Strong Buy
Hold
Analyst Count
15
3
Target Price
$120.67
★ $335.00
AVG Volume (30 Days)
★ 776.4K
214.5K
Earning Date
12-01-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
125.69
★ 142.61
EPS
1.60
★ 11.25
Revenue
$229,525,000.00
★ $2,583,200,000.00
Revenue This Year
$7.87
N/A
Revenue Next Year
$7.77
$2.13
P/E Ratio
$67.80
★ $33.73
Revenue Growth
★ 28.68
0.65
52 Week Low
$72.76
$236.73
52 Week High
$109.37
$396.23

Technical Indicators

Market Signals
Indicator
HQY
BIO
Relative Strength Index (RSI) 58.29 56.37
Support Level $101.58 $350.29
Resistance Level $106.59 $391.44
Average True Range (ATR) 3.59 12.95
MACD 0.45 1.08
Stochastic Oscillator 56.54 80.74

Price Performance

Historical Comparison
HQY
BIO

About HQY HealthEquity Inc.

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: